Fine et al. reported that the median concentration of paclitaxel was 2.46-fold higher in the periphery of metastatic brain tumors as compared with gliomas suggesting decreased BBB function likely secondary to decreased expression of P-gp in neovascular endothelial cells of metastatic brain tumors [22]. This evidence concerns the gene PGP and central nervous system cancer.